News | May 19, 2026
Lupin debuts in Dow Jones best-in-class indices for ESG performance
The global pharmaceutical company has been featured in both the DJBIC World Index and the DJBIC Emerging Markets Index
The global pharmaceutical company has been featured in both the DJBIC World Index and the DJBIC Emerging Markets Index
With over 30 years of pharmaceutical industry experience, Ponnusamy will lead Alembic’s animal health business strategy, market expansion, and operational growth initiatives
Over the past decade, IIL has maintained a strong growth trajectory, registering a compound annual growth rate (CAGR) of 16%
Former Cipla MD & CEO to lead next phase of growth at science-led CDMO platform; Vivek Sharma transitions to advisory role
Subscribe To Our Newsletter & Stay Updated
